Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 236

1.

Recurrent IgA nephropathy after renal transplantation and steroid withdrawal.

Di Vico MC, Messina M, Fop F, Barreca A, Segoloni GP, Biancone L.

Clin Transplant. 2018 Apr;32(4):e13207. doi: 10.1111/ctr.13207. Epub 2018 Feb 20.

PMID:
29345747
2.

Long-Term Outcomes and Discard Rate of Kidneys by Decade of Extended Criteria Donor Age.

Messina M, Diena D, Dellepiane S, Guzzo G, Lo Sardo L, Fop F, Segoloni GP, Amoroso A, Magistroni P, Biancone L.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):323-331. doi: 10.2215/CJN.06550616. Epub 2016 Dec 15.

3.

Treatment protocol with pulse and oral steroids for IgA Nephropathy after kidney transplantation.

Messina M, di Vico MC, Ariaudo C, Mazzucco G, Fop F, Segoloni GP, Biancone L.

J Nephrol. 2016 Aug;29(4):575-83. doi: 10.1007/s40620-016-0314-5. Epub 2016 May 23.

PMID:
27217158
4.

Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation.

Ranghino A, Diena D, Simonato F, Messina M, Burdese M, Piraina V, Fop F, Segoloni GP, Biancone L.

Springerplus. 2016 Jan 4;5:7. doi: 10.1186/s40064-015-1658-3. eCollection 2016.

5.

Lymphatic disorders after renal transplantation: new insights for an old complication.

Ranghino A, Segoloni GP, Lasaponara F, Biancone L.

Clin Kidney J. 2015 Oct;8(5):615-22. doi: 10.1093/ckj/sfv064. Epub 2015 Jul 16. Review.

6.

Relationship among C1q-fixing de novo donor specific antibodies, C4d deposition and renal outcome in transplant glomerulopathy.

Messina M, Ariaudo C, Praticò Barbato L, Beltramo S, Mazzucco G, Amoroso A, Ranghino A, Cantaluppi V, Fop F, Segoloni GP, Biancone L.

Transpl Immunol. 2015 Sep;33(1):7-12. doi: 10.1016/j.trim.2015.06.002. Epub 2015 Jul 6. Review.

PMID:
26160049
7.

Neutrophil Gelatinase Associated Lipocalin Is an Early and Accurate Biomarker of Graft Function and Tissue Regeneration in Kidney Transplantation from Extended Criteria Donors.

Cantaluppi V, Dellepiane S, Tamagnone M, Medica D, Figliolini F, Messina M, Manzione AM, Gai M, Tognarelli G, Ranghino A, Dolla C, Ferrario S, Tetta C, Segoloni GP, Camussi G, Biancone L.

PLoS One. 2015 Jun 30;10(6):e0129279. doi: 10.1371/journal.pone.0129279. eCollection 2015.

8.

mTOR inhibitors for medical treatment of post-transplantation encapsulating peritoneal sclerosis: a favourable single center experience.

Messina M, Ariaudo C, Mella A, Cantaluppi V, Segoloni GP, Biancone L.

J Nephrol. 2015 Apr;28(2):245-9. doi: 10.1007/s40620-014-0168-7. Epub 2015 Jan 14.

PMID:
25585825
9.

Assessment of platelet function analyzer (PFA-100) in kidney transplant patients before renal allograft biopsy: a retrospective single-center analysis.

Ranghino A, Mella A, Borchiellini A, Nappo A, Manzione AM, Gallo E, Giovinazzo G, Fop F, Segoloni GP, Biancone L.

Transplant Proc. 2014 Sep;46(7):2259-62. doi: 10.1016/j.transproceed.2014.07.052.

PMID:
25242765
10.

Pulmonary toxicity in a renal transplant recipient treated with amiodarone and everolimus: a case of hypothetical synergy and a proposal for a screening protocol.

Mella A, Messina M, Ranghino A, Solidoro P, Tabbia G, Segoloni GP, Biancone L.

Case Rep Nephrol Urol. 2014 Apr 12;4(1):75-81. doi: 10.1159/000362361. eCollection 2014 Jan.

11.

Mitochondrial neurogastrointestinal encephalomyopathy treated with peritoneal dialysis and bone marrow transplantation.

Ariaudo C, Daidola G, Ferrero B, Guarena C, Burdese M, Segoloni GP, Biancone L.

J Nephrol. 2015 Feb;28(1):125-7. doi: 10.1007/s40620-014-0069-9. Epub 2014 Mar 6.

PMID:
24599829
12.

A newly identified mutation in the complement factor I gene not associated with early post-transplant recurrence of atypical hemolytic-uremic syndrome: a case report.

Ranghino A, Tognarelli G, Basso E, Messina M, Manzione AM, Daidola G, Segoloni GP.

Transplant Proc. 2013 Sep;45(7):2785-7. doi: 10.1016/j.transproceed.2013.07.012.

PMID:
24034049
13.

A case report of AA amyloidosis associated with familial periodic fever syndrome diagnosed after kidney transplantation: never say never.

Messina M, Daidola G, Restagno G, Lavacca A, Ranghino A, Biancone L, Segoloni GP.

Transplant Proc. 2013 Sep;45(7):2778-81. doi: 10.1016/j.transproceed.2013.07.043.

14.

Evaluation of Epstein-Barr virus-specific immunologic response in solid organ transplant recipients with an enzyme-linked ImmunoSpot assay.

Rittà M, Costa C, Sinesi F, Sidoti F, Di Nauta A, Mantovani S, Piceghello A, Simeone S, Ricci D, Boffini M, Solidoro P, Baldi S, Segoloni GP, Cavallo R.

Transplant Proc. 2013 Sep;45(7):2754-7. doi: 10.1016/j.transproceed.2013.07.033.

PMID:
24034040
15.

[A 8-year-forgotten ureteral stent after kidney transplantation: treatment and long-term follow-up].

Lasaponara F, Dalmasso E, Santià S, Sedigh O, Bosio A, Pasquale G, Segoloni GP, Fontana D.

Urologia. 2013 Jan-Mar;80(1):80-2. doi: 10.5301/RU.2013.10743. Epub 2013 Feb 14. Italian.

PMID:
23423682
16.

Phosphodiesterase type 5 inhibitor treatment for erectile dysfunction in patients with end-stage renal disease receiving dialysis or after renal transplantation.

Lasaponara F, Sedigh O, Pasquale G, Bosio A, Rolle L, Ceruti C, Timpano M, Negro CL, Paradiso M, Abbona A, Segoloni GP, Fontana D.

J Sex Med. 2013 Nov;10(11):2798-814. doi: 10.1111/jsm.12038. Epub 2013 Jan 24.

17.

A case of recurrent proliferative glomerulonephritis with monoclonal IgG deposits after kidney transplant treated with plasmapheresis.

Ranghino A, Tamagnone M, Messina M, Barreca A, Biancone L, Basolo B, Segoloni GP, Mazzucco G.

Case Rep Nephrol Urol. 2012 Jan;2(1):46-52. doi: 10.1159/000339405. Epub 2012 Jun 5.

18.

Different regulatory and cytotoxic CD4+ T lymphocyte profiles in renal transplants with antibody-mediated chronic rejection or long-term good graft function.

Giaretta F, Bussolino S, Beltramo S, Fop F, Rossetti M, Messina M, Cantaluppi V, Ranghino A, Basso E, Camussi G, Segoloni GP, Biancone L.

Transpl Immunol. 2013 Jan;28(1):48-56. doi: 10.1016/j.trim.2012.11.003. Epub 2012 Nov 22.

PMID:
23178518
19.

[Immunosuppressive treatment after kidney transplant: the frontier of chronic antibody-mediated rejection].

Biancone L, Lavacca A, Beltramo S, Ariaudo C, Gallo E, Segoloni GP.

G Ital Nefrol. 2012 Sep-Oct;29(5):579-91. Review. Italian.

PMID:
23117738
20.

Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.

Piselli P, Serraino D, Segoloni GP, Sandrini S, Piredda GB, Scolari MP, Rigotti P, Busnach G, Messa P, Donati D, Schena FP, Maresca MC, Tisone G, Veroux M, Sparacino V, Pisani F, Citterio F; Immunosuppression and Cancer Study Group.

Eur J Cancer. 2013 Jan;49(2):336-44. doi: 10.1016/j.ejca.2012.09.013. Epub 2012 Oct 10.

PMID:
23062667
21.

Monitoring of inosine monophosphate dehydrogenase activity and expression during the early period of mycophenolate mofetil therapy in de novo renal transplant patients.

Molinaro M, Chiarelli LR, Biancone L, Castagneto M, Boschiero L, Pisani F, Sabbatini M, Sandrini S, Arbustini E, Tinelli C, Regazzi M, Schena FP, Segoloni GP.

Drug Metab Pharmacokinet. 2013;28(2):109-17. Epub 2012 Aug 14.

22.

Intraoperative superselective embolization of a biopsy-related arteriocalyceal fistula during a kidney transplantation.

Bosio A, Lasaponara F, Dalmasso E, Breatta AD, Pasquale G, Sedigh O, Verri A, Negro CL, Alessandria E, Righi D, Segoloni GP, Fontana D.

Transplantation. 2012 Jul 27;94(2):e12-3. doi: 10.1097/TP.0b013e31825ace84. No abstract available.

PMID:
22820560
23.

Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia.

Ranghino A, Cantaluppi V, Grange C, Vitillo L, Fop F, Biancone L, Deregibus MC, Tetta C, Segoloni GP, Camussi G.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):75-85.

PMID:
22507320
24.

Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets.

Cantaluppi V, Biancone L, Figliolini F, Beltramo S, Medica D, Deregibus MC, Galimi F, Romagnoli R, Salizzoni M, Tetta C, Segoloni GP, Camussi G.

Cell Transplant. 2012;21(6):1305-20. doi: 10.3727/096368911X627534. Epub 2012 Mar 22.

25.

Anidulafungin treatment in a kidney transplant recipient with hepatic damage.

De Rosa FG, Manzione NA, Ranghino A, Messina M, Ottobrelli A, Raviolo S, Di Perri G, Segoloni GP.

Mycoses. 2011 Dec;54 Suppl 4:12-5. doi: 10.1111/j.1439-0507.2011.02137.x.

PMID:
22126524
26.

Combined measurement of serum DNA and urine VP1 messenger RNA in monitoring BK virus replication in kidney graft recipients.

Astegiano S, Bergallo M, Terlizzi ME, Sidoti F, Gambarino S, Messina M, Costa C, Segoloni GP, Cavallo R.

Transplant Proc. 2011 May;43(4):1052-4. doi: 10.1016/j.transproceed.2011.01.118.

PMID:
21620051
27.

Impact of contrast-induced acute kidney injury definition on clinical outcomes.

Budano C, Levis M, D'Amico M, Usmiani T, Fava A, Sbarra P, Burdese M, Segoloni GP, Colombo A, Marra S.

Am Heart J. 2011 May;161(5):963-71. doi: 10.1016/j.ahj.2011.02.004.

PMID:
21570530
28.

Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study.

Savoia P, Stroppiana E, Cavaliere G, Osella-Abate S, Mezza E, Segoloni GP, Bernengo MG.

Eur J Dermatol. 2011 Mar-Apr;21(2):242-7. doi: 10.1684/ejd.2011.1272.

PMID:
21382788
29.

Genotyping of polyomavirus BK by Real Time PCR for VP1 gene.

Gambarino S, Costa C, Astegiano S, Piasentin EA, Segoloni GP, Cavallo R, Bergallo M.

Mol Biotechnol. 2011 Oct;49(2):151-8. doi: 10.1007/s12033-011-9386-6.

30.

[Lymphomatous renal involvement].

Besso L, Quercia AD, Daidola G, Burdese M, Colla L, Basso E, Karvela E, Marcuccio C, Tarella C, Segoloni GP.

G Ital Nefrol. 2010 Sep-Oct;27 Suppl 50:S34-9. Italian.

PMID:
20922693
31.

Loss of nephrin expression in glomeruli of kidney-transplanted patients under m-TOR inhibitor therapy.

Biancone L, Bussolati B, Mazzucco G, Barreca A, Gallo E, Rossetti M, Messina M, Nuschak B, Fop F, Medica D, Cantaluppi V, Camussi G, Segoloni GP.

Am J Transplant. 2010 Oct;10(10):2270-8. doi: 10.1111/j.1600-6143.2010.03259.x. Epub 2010 Sep 14.

32.

Analysis of four scoring systems and monocentric experience to optimize criteria for marginal kidney transplantation.

Messina M, Fop F, Gallo E, Tamagnone M, Segoloni GP.

Transplant Proc. 2010 Jul-Aug;42(6):2209-13. doi: 10.1016/j.transproceed.2010.05.038.

PMID:
20692446
33.

Real-time RT-PCR assay for the quantitation of polyomavirus BK VP1 mRNA levels in urine.

Bergallo M, Astegiano S, Sidoti F, Mantovani S, Segoloni GP, Cavallo R, Costa C.

Mol Biotechnol. 2010 May;45(1):82-6. doi: 10.1007/s12033-010-9245-x.

34.

Protective effect of resin adsorption on septic plasma-induced tubular injury.

Cantaluppi V, Weber V, Lauritano C, Figliolini F, Beltramo S, Biancone L, De Cal M, Cruz D, Ronco C, Segoloni GP, Tetta C, Camussi G.

Crit Care. 2010;14(1):R4. doi: 10.1186/cc8835. Epub 2010 Jan 11.

35.

[The history of peritoneal dialysis at the Molinette Hospital in Turin, Italy].

Pacitti A, Maffei S, Segoloni GP.

G Ital Nefrol. 2009 Nov-Dec;26(6):709-18. Italian.

PMID:
19918754
36.

[Transplantation before dialysis: a statement in favor].

Segoloni GP.

G Ital Nefrol. 2009 Nov-Dec;26(6):650-3. Italian.

PMID:
19918745
37.

Non-organ-specific and anti-endothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients.

Costa C, Touscoz GA, Bergallo M, Terlizzi ME, Astegiano S, Sidoti F, Sinesi F, Segoloni GP, Cavallo R.

Clin Transplant. 2010 Jul-Aug;24(4):488-92. doi: 10.1111/j.1399-0012.2009.01092.x.

PMID:
19758268
38.

Assessment of cardiovascular risk in waiting-listed renal transplant patients: a single center experience in 558 cases.

Leonardi G, Tamagnone M, Ferro M, Tognarelli G, Messina M, Giraudi R, Fop F, Picciotto G, Biancone L, Segoloni GP.

Clin Transplant. 2009 Sep-Oct;23(5):653-9. doi: 10.1111/j.1399-0012.2009.01018.x. Epub 2009 Jun 26.

PMID:
19563485
39.

[Kidney retransplantation: indications and limits].

Segoloni GP, Messina M, Basso E, Quercia A, Fop F.

G Ital Nefrol. 2009 Mar-Apr;26(2):191-200. Review. Italian.

PMID:
19382075
40.

'Bench' MRI before transplant on harvested kidneys: a possible tool for diagnosis of acute pyelonephritis.

Mezza E, Biancone L, Tattoli F, Messina M, Rizzo L, Tola E, Segoloni GP.

Nephrol Dial Transplant. 2009 Feb;24(2):670-2. doi: 10.1093/ndt/gfn618. Epub 2008 Nov 11.

PMID:
19001562
41.

Polyomaviruses BK- And JC-DNA quantitation in kidney allograft biopsies.

Costa C, Bergallo M, Sidoti F, Astegiano S, Terlizzi ME, Mazzucco G, Segoloni GP, Cavallo R.

J Clin Virol. 2009 Jan;44(1):20-3. doi: 10.1016/j.jcv.2008.08.006. Epub 2008 Sep 25.

42.

Severe crescentic BK virus nephropathy with favourable outcome in a transplanted patient treated with Leflunomide.

Mazzucco G, Costa C, Bergallo M, Segoloni GP, Monga G.

Clin Nephrol. 2008 Aug;70(2):163-7.

PMID:
18793533
43.

B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.

Praticò-Barbato L, Conca R, Magistroni P, Leonardi G, Oda A, Rosati F, Leone E, Tacconella M, Roggero S, Segoloni GP, Amoroso A.

Transpl Immunol. 2008 Jul;19(3-4):238-43. doi: 10.1016/j.trim.2008.05.002. Epub 2008 Jun 6.

PMID:
18675725
44.

Non-organ-specific autoantibodies in renal transplant recipients: relation to BK virus infection.

Costa C, Touscoz GA, Bergallo M, Sidoti F, Terlizzi ME, Astegiano S, Merlino C, Segoloni GP, Cavallo R.

New Microbiol. 2008 Apr;31(2):175-80.

45.

Macrophage stimulating protein may promote tubular regeneration after acute injury.

Cantaluppi V, Biancone L, Romanazzi GM, Figliolini F, Beltramo S, Galimi F, Camboni MG, Deriu E, Conaldi P, Bottelli A, Orlandi V, Herrera MB, Pacitti A, Segoloni GP, Camussi G.

J Am Soc Nephrol. 2008 Oct;19(10):1904-18. doi: 10.1681/ASN.2007111209. Epub 2008 Jul 9.

46.

[Preventive renal transplantation: considerations and future plans].

Segoloni GP.

G Ital Nefrol. 2008 May-Jun;25 Suppl 41:S3-6, discussion S6-8. Italian.

PMID:
18473313
47.

Monitoring of BK virus replication in the first year following renal transplantation.

Costa C, Bergallo M, Astegiano S, Terlizzi ME, Sidoti F, Segoloni GP, Cavallo R.

Nephrol Dial Transplant. 2008 Oct;23(10):3333-6. doi: 10.1093/ndt/gfn289. Epub 2008 May 25.

PMID:
18503098
48.

Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies.

Terlizzi ME, Costa C, Astegiano S, Sidoti F, Vendrame R, Segoloni GP, Bergallo M, Cavallo R.

Minerva Med. 2008 Jun;99(3):231-9. English, Italian.

PMID:
18497721
49.

Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors.

Cantaluppi V, Assenzio B, Pasero D, Romanazzi GM, Pacitti A, Lanfranco G, Puntorieri V, Martin EL, Mascia L, Monti G, Casella G, Segoloni GP, Camussi G, Ranieri VM.

Intensive Care Med. 2008 Sep;34(9):1638-45. doi: 10.1007/s00134-008-1124-6. Epub 2008 May 8.

50.

Human polyomavirus BK in patients with lupus nephritis: clinical and histological correlations.

Colla L, Mesiano P, Morellini V, Besso L, Cavallo R, Bergallo M, Costa C, Merlino C, Marcuccio C, Fop F, Lanfranco G, Segoloni GP, Canavese C, Stratta P.

Lupus. 2007;16(11):881-6.

PMID:
17971361

Supplemental Content

Loading ...
Support Center